Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 100,652 shares at $50.24 ($5.1M) on 2025-07-16, disclosed to the SEC on 2025-07-18.
Scheduled sale ($5.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.24 | 46,076 | $2.3M | 45.7% |
| 2 | $50.24 | 46,076 | $2.3M | 45.7% |
| 3 | $50.58 | 2,792 | $141K | 2.8% |
| 4 | $50.58 | 2,792 | $141K | 2.8% |
| 5 | $50.82 | 1,458 | $74K | 1.5% |
| 6 | $50.82 | 1,458 |
| $74K |
| 1.5% |
| Total | $50.28 avg | 100,652 | $5.1M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |